DATAPHARM LIMITED

Active Leatherhead
47 employees website.com
Life sciences and medical technology
D

DATAPHARM LIMITED

Founded 26 Mar 2018 Active Leatherhead, England 47 employees website.com
Life sciences and medical technology
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 26 Mar 2026 Next due 8 Apr 2027 11 months remaining
Net assets £1M £1M 2024 year on year
Total assets £15M £1M 2024 year on year
Total Liabilities £14M £3M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Cassini Court Randalls Way Leatherhead Surrey KT22 7TW England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for DATAPHARM LIMITED (11275607), an active life sciences and medical technology company based in Leatherhead, England. Incorporated 26 Mar 2018. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2018–2024)

Cash in Bank

£6.52M

Increased by £1.19M (+22%)

Net Assets

£1.22M

Decreased by £1.13M (-48%)

Total Liabilities

£13.53M

Increased by £2.54M (+23%)

Turnover

£10.16M

Increased by £2.54M (+33%)

Employees

47

Increased by 6 (+15%)

Debt Ratio

92%

Increased by 10 (+12%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2022Private Equity

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 26,150 Shares £128k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Feb 20226,500£65£0.01
23 Feb 20222,550£99k£38.74
23 Feb 20223,450£29k£8.32
23 Feb 20226,650£66.5£0.01
20 May 20211,000£10£0.01

Officers

Officers

1 active 2 resigned
Status
Richard CooperDirectorBritishUnited Kingdom521 Mar 2023Active

Shareholders

Shareholders (1)

Summer Bidco Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Summer Bidco Limited

United Kingdom

Active
Notified 23 Feb 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Graham Francis Rich

Ceased 23 Feb 2022

Ceased

Simon Maxwell Abrams

Ceased 23 Feb 2022

Ceased

Group Structure

Group Structure

CGE PARTNERS LLP united kingdom
SUMMER TOPCO LIMITED united kingdom
SUMMER MIDCO LIMITED united kingdom
SUMMER BIDCO LIMITED united kingdom
DATAPHARM LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Mar 2026Confirmation StatementConfirmation statement made on 2026-03-25 with updates
26 Mar 2026OfficersChange to director Mr James Paul George Wigg on 2026-02-27
2 Oct 2025OfficersAppointment of Mr Robert Lloyd Morgan as director on 2025-09-24
29 Sept 2025AccountsAnnual accounts made up to 2024-12-31
15 Sept 2025OfficersTermination of Richard Cooper as director on 2025-09-03
26 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-03-25 with updates

26 Mar 2026 Officers

Change to director Mr James Paul George Wigg on 2026-02-27

2 Oct 2025 Officers

Appointment of Mr Robert Lloyd Morgan as director on 2025-09-24

29 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

15 Sept 2025 Officers

Termination of Richard Cooper as director on 2025-09-03

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-25 with updates

3 weeks ago on 26 Mar 2026

Change to director Mr James Paul George Wigg on 2026-02-27

3 weeks ago on 26 Mar 2026

Appointment of Mr Robert Lloyd Morgan as director on 2025-09-24

6 months ago on 2 Oct 2025

Annual accounts made up to 2024-12-31

6 months ago on 29 Sept 2025

Termination of Richard Cooper as director on 2025-09-03

7 months ago on 15 Sept 2025